Trademark applications and grants for Santen Pharmaceutical Co L T D. Santen Pharmaceutical Co L T D has 51 trademark applications. The latest application filed is for "OMPTERA"
Patent Application | Date |
---|---|
LIPOIC ACID PRODRUG 20220151989 - 17/604054 KATO; Masatomo ;   et al. | 2022-05-19 |
OPTICAL PROBE 20220126112 - 17/425037 KAMIKATANO; Mitsuru ;   et al. | 2022-04-28 |
URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA 20220096497 - 17/546895 KATO; Masatomo ;   et al. | 2022-03-31 |
URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA 20220072012 - 17/414285 KATO; Masatomo ;   et al. | 2022-03-10 |
AGENT CONTAINING 4-PHENYLBUTYRATE, FOR PREVENTING OR TREATING PRESBYOPIA 20220062209 - 17/414286 KATO; Masatomo ;   et al. | 2022-03-03 |
SEC | 0001501108 | Santen Pharmaceutical Co Ltd/ADR |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.